0001613103H91 VY19false00016131032024-10-172024-10-170001613103us-gaap:CommonStockMember2024-10-172024-10-170001613103mdt:A0.250SeniorNotesDue2025Member2024-10-172024-10-170001613103mdt:A0.000SeniorNotesDue2025Member2024-10-172024-10-170001613103mdt:A2.625SeniorNotesDue2025Member2024-10-172024-10-170001613103mdt:A1.125SeniorNotesDue2027Member2024-10-172024-10-170001613103mdt:A0.375SeniorNotesDue2028Member2024-10-172024-10-170001613103mdt:A3.000SeniorNotesDue2028Member2024-10-172024-10-170001613103mdt:A3.650SeniorNotesDue2029Member2024-10-172024-10-170001613103mdt:A1.625SeniorNotesDue2031Member2024-10-172024-10-170001613103mdt:A1.000SeniorNotesDue2031Member2024-10-172024-10-170001613103mdt:A3.125SeniorNotesDue2031Member2024-10-172024-10-170001613103mdt:A0.750SeniorNotesDue2032Member2024-10-172024-10-170001613103mdt:A3.375SeniorNotesDue2034Member2024-10-172024-10-170001613103mdt:A3.875SeniorNotesDue2036Member2024-10-172024-10-170001613103mdt:A2.250SeniorNotesDue2039Member2024-10-172024-10-170001613103mdt:A1.500SeniorNotesDue2039Member2024-10-172024-10-170001613103mdt:A1.375SeniorNotesDue2040Member2024-10-172024-10-170001613103mdt:A4.150SeniorNotesDue2043Member2024-10-172024-10-170001613103mdt:A1.750SeniorNotesDue2049Member2024-10-172024-10-170001613103mdt:A1.625SeniorNotesDue2050Member2024-10-172024-10-170001613103mdt:A4.150SeniorNotesDue2053Member2024-10-172024-10-17

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
_____________________________ 
FORM 8-K
 _____________________________ 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 17, 2024
 _____________________________ 
Medtronic plc
(Exact name of Registrant as Specified in its Charter)
  _____________________________ 
 
Ireland 1-36820 98-1183488
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)

Building Two
Parkmore Business Park West
Galway, Ireland
(Address of principal executive offices) (Zip Code)
+353 1 438-1700
(Registrant’s telephone number, including area code)
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))












Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Ordinary shares, par value $0.0001 per shareMDTNew York Stock Exchange
0.250% Senior Notes due 2025MDT/25New York Stock Exchange
0.000% Senior Notes due 2025MDT/25ANew York Stock Exchange
2.625% Senior Notes due 2025MDT/25BNew York Stock Exchange
1.125% Senior Notes due 2027MDT/27New York Stock Exchange
0.375% Senior Notes due 2028MDT/28New York Stock Exchange
3.000% Senior Notes due 2028MDT/28ANew York Stock Exchange
3.650% Senior Notes due 2029MDT/29New York Stock Exchange
1.625% Senior Notes due 2031MDT/31New York Stock Exchange
1.000% Senior Notes due 2031MDT/31ANew York Stock Exchange
3.125% Senior Notes due 2031MDT/31BNew York Stock Exchange
0.750% Senior Notes due 2032MDT/32New York Stock Exchange
3.375% Senior Notes due 2034MDT/34New York Stock Exchange
3.875% Senior Notes due 2036MDT/36New York Stock Exchange
2.250% Senior Notes due 2039MDT/39ANew York Stock Exchange
1.500% Senior Notes due 2039MDT/39BNew York Stock Exchange
1.375% Senior Notes due 2040MDT/40ANew York Stock Exchange
4.150% Senior Notes due 2043MDT/43ANew York Stock Exchange
1.750% Senior Notes due 2049MDT/49New York Stock Exchange
1.625% Senior Notes due 2050MDT/50New York Stock Exchange
4.150% Senior Notes due 2053MDT/53New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 5.07.Submission of Matters to a Vote of Security Holders.
On October 17, 2024, the Company held its 2024 Annual General Meeting of Shareholders in order to: (1) elect, by separate resolutions, ten directors, each to hold office until the 2025 Annual General Meeting of the Company and until his or her successor is elected; (2) ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for fiscal year 2025 and authorize, in a binding vote, the Company’s Board of Directors, acting through the Audit Committee, to set the auditor’s remuneration; (3) approve, in a non-binding advisory vote, named executive officer compensation; (4) renew the Board’s authority to issue shares; (5) renew the Board’s authority to opt out of pre-emption rights; and (6) authorize the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.
At the close of business on August 23, 2024, the record date of the Annual General Meeting, 1,282,467,348 Company ordinary shares were outstanding and entitled to vote. The holders of a total of 1,118,364,589 ordinary shares were present at the Annual General Meeting, either in person or by proxy, which total was not less than a majority of the issued and outstanding ordinary shares entitled to vote and thus constituted a quorum.
The final voting results and the votes used to determine the results for each proposal are set forth below:
1. The shareholders elected each of the ten nominees to the Board of Directors, to hold office until the 2025 Annual General Meeting of the Company and until his or her successor is elected, as follows:
FOR
AGAINST
ABSTAIN
BROKER
NON-VOTE
Craig Arnold
952,980,300
45,113,878
1,927,552
118,342,859
Scott C. Donnelly
964,223,711
34,734,436
1,063,583
118,342,859
Lidia L. Fonseca
983,895,789
15,081,990
1,043,951
118,342,859
Andrea J. Goldsmith, Ph.D.
994,796,259
4,135,950
1,089,521
118,342,859
Randall J. Hogan, III
992,550,812
6,398,816
1,072,102
118,342,859
Gregory P. Lewis
985,323,082
13,626,512
1,072,136
118,342,859
Kevin E. Lofton
990,923,667
8,030,691
1,067,372
118,342,859
Geoffrey S. Martha
943,041,061
53,318,321
3,662,348
118,342,859
Elizabeth G. Nabel, M.D.
966,622,750
32,366,858
1,032,122
118,342,859
Kendall J. Powell
906,406,435
91,375,803
2,239,492
118,342,859
2. The shareholders ratified, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as Medtronic’s independent auditor for fiscal year 2025 and to authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor’s remuneration.
FOR
AGAINST
ABSTAIN
1,008,653,733
107,729,791
1,981,065
3. The shareholders approved, on a non-binding advisory basis, the compensation awarded to the Company’s named executive officers.
FOR
AGAINST
ABSTAIN
BROKER NON-VOTE
924,541,222
70,301,925
5,178,583
118,342,859
4. The shareholders approved renewal of the Board’s authority to issue shares.
FOR
AGAINST
ABSTAIN
1,094,709,167
17,315,138
6,340,284


5. The shareholders approved renewal of the Board’s authority to opt out of pre-emption rights.
FOR
AGAINST
ABSTAIN
1,042,690,218
68,667,595
7,006,776
6. The shareholders approved authorization of the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.
FOR
AGAINST
ABSTAIN
1,086,792,639
27,683,267
3,888,683
Item 9.01.Exhibits.
(d) List of Exhibit
Exhibit Number  Description
104
Cover Page Interactive Data File (embedded with the Inline XBRL document).







SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
   Medtronic plc
  By 
/s/ Ivan K. Fong
Date: October 21, 2024   
Ivan K. Fong
   Executive Vice President, General Counsel and Secretary






EXHIBIT INDEX
Exhibit Number  Description
104
Cover Page Interactive Data File (embedded with the Inline XBRL document).



v3.24.3
Cover
Oct. 17, 2024
Entity Information [Line Items]  
Document Type 8-K
Document Period End Date Oct. 17, 2024
Entity Incorporation, State or Country Code L2
Entity File Number 1-36820
Entity Tax Identification Number 98-1183488
Entity Address, Address Line One Building Two
Entity Address, Address Line Two Parkmore Business Park West
Entity Address, City or Town Galway
Entity Address, Country IE
Country Region 353
City Area Code 1
Local Phone Number 438-1700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001613103
Entity Registrant Name Medtronic plc
Entity Address, Postal Zip Code H91 VY19
Amendment Flag false
Ordinary shares, par value $0.0001 per share  
Entity Information [Line Items]  
Title of 12(b) Security Ordinary shares, par value $0.0001 per share
Trading Symbol MDT
Security Exchange Name NYSE
0.250% Senior Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 0.250% Senior Notes due 2025
Trading Symbol MDT/25
Security Exchange Name NYSE
0.000% Senior Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 0.000% Senior Notes due 2025
Trading Symbol MDT/25A
Security Exchange Name NYSE
2.625% Senior Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 2.625% Senior Notes due 2025
Trading Symbol MDT/25B
Security Exchange Name NYSE
1.125% Senior Notes due 2027  
Entity Information [Line Items]  
Title of 12(b) Security 1.125% Senior Notes due 2027
Trading Symbol MDT/27
Security Exchange Name NYSE
0.375% Senior Notes due 2028  
Entity Information [Line Items]  
Title of 12(b) Security 0.375% Senior Notes due 2028
Trading Symbol MDT/28
Security Exchange Name NYSE
3.000% Senior Notes due 2028  
Entity Information [Line Items]  
Title of 12(b) Security 3.000% Senior Notes due 2028
Trading Symbol MDT/28A
Security Exchange Name NYSE
3.650% Senior Notes due 2029  
Entity Information [Line Items]  
Title of 12(b) Security 3.650% Senior Notes due 2029
Trading Symbol MDT/29
Security Exchange Name NYSE
1.625% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 1.625% Senior Notes due 2031
Trading Symbol MDT/31
Security Exchange Name NYSE
1.000% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 1.000% Senior Notes due 2031
Trading Symbol MDT/31A
Security Exchange Name NYSE
3.125% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 3.125% Senior Notes due 2031
Trading Symbol MDT/31B
Security Exchange Name NYSE
0.750% Senior Notes due 2032  
Entity Information [Line Items]  
Title of 12(b) Security 0.750% Senior Notes due 2032
Trading Symbol MDT/32
Security Exchange Name NYSE
3.375% Senior Notes due 2034  
Entity Information [Line Items]  
Title of 12(b) Security 3.375% Senior Notes due 2034
Trading Symbol MDT/34
Security Exchange Name NYSE
3.875% Senior Notes due 2036  
Entity Information [Line Items]  
Title of 12(b) Security 3.875% Senior Notes due 2036
Trading Symbol MDT/36
Security Exchange Name NYSE
2.250% Senior Notes due 2039  
Entity Information [Line Items]  
Title of 12(b) Security 2.250% Senior Notes due 2039
Trading Symbol MDT/39A
Security Exchange Name NYSE
1.500% Senior Notes due 2039  
Entity Information [Line Items]  
Title of 12(b) Security 1.500% Senior Notes due 2039
Trading Symbol MDT/39B
Security Exchange Name NYSE
1.375% Senior Notes due 2040  
Entity Information [Line Items]  
Title of 12(b) Security 1.375% Senior Notes due 2040
Trading Symbol MDT/40A
Security Exchange Name NYSE
4.150% Senior Notes due 2043  
Entity Information [Line Items]  
Title of 12(b) Security 4.150% Senior Notes due 2043
Trading Symbol MDT/43A
Security Exchange Name NYSE
1.750% Senior Notes due 2049  
Entity Information [Line Items]  
Title of 12(b) Security 1.750% Senior Notes due 2049
Trading Symbol MDT/49
Security Exchange Name NYSE
1.625% Senior Notes due 2050  
Entity Information [Line Items]  
Title of 12(b) Security 1.625% Senior Notes due 2050
Trading Symbol MDT/50
Security Exchange Name NYSE
4.150% Senior Notes due 2053  
Entity Information [Line Items]  
Title of 12(b) Security 4.150% Senior Notes due 2053
Trading Symbol MDT/53
Security Exchange Name NYSE
Medtronic (NYSE:MDT)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024 Medtronic 차트를 더 보려면 여기를 클릭.
Medtronic (NYSE:MDT)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024 Medtronic 차트를 더 보려면 여기를 클릭.